Literature DB >> 6026788

The treatment of scopolamine-induced delirium with physostigmine.

E B Crowell, J S Ketchum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6026788     DOI: 10.1002/cpt196783409

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

1.  Experiences with physostigmine in the reversal of adverse post-anaesthetic effects.

Authors:  J Brebner; L Hadley
Journal:  Can Anaesth Soc J       Date:  1976-11

2.  Postoperative delirium secondary to atropine premedication.

Authors:  K Hammon; B K DeMartino
Journal:  Anesth Prog       Date:  1985 May-Jun

3.  A randomized evaluation of the reversal of ketamine by physostigmine.

Authors:  J C Drummond; J Brebner; S Galloon; P S Young
Journal:  Can Anaesth Soc J       Date:  1979-07

4.  Effects of physostigmine, scopolamine, and mecamylamine on the sleeping time induced by ketamine in the rat.

Authors:  E M Figallo; L B Wingard
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

5.  The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.

Authors:  Joseph W Watkins; Evan S Schwarz; Anna M Arroyo-Plasencia; Michael E Mullins
Journal:  J Med Toxicol       Date:  2015-06

Review 6.  Drug-induced psychiatric disorders.

Authors:  D A Johnson
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

7.  Scopolamine intoxications.

Authors:  L F Lauwers; R Daelemans; L Baute; H Verbraeken
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

8.  Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.

Authors:  M M Ghoneim; S P Mewaldt
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

Review 9.  Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatment.

Authors:  J M Klafta; J P Zacny; C J Young
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

10.  The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task.

Authors:  P M Grasby; C D Frith; E Paulesu; K J Friston; R S Frackowiak; R J Dolan
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.